Clinical Trial Update: Safety and Efficacy of QBECO in Moderate to Severe Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial of QBECO for moderate-to-severe ulcerative colitis has completed, reporting on safety and efficacy outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• QBECO

Snippet

Sponsor: Qu Biologics Inc. | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED